N-[2-[4-(1,3-benzodioxole-5-carbonyl)piperazin-1-yl]ethyl]-N-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2-phenylacetamide

C32H35N3O5 — CID 1061272

IUPACN-[2-[4-(1,3-benzodioxole-5-carbonyl)piperazin-1-yl]ethyl]-N-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2-phenylacetamide
SMILESCOc1ccccc1/C=C/CN(CCN1CCN(C(=O)c2ccc3c(c2)OCO3)CC1)C(=O)Cc1ccccc1
InChIInChI=1S/C32H35N3O5/c1-38-28-12-6-5-10-26(28)11-7-15-34(31(36)22-25-8-3-2-4-9-25)19-16-33-17-20-35(21-18-33)32(37)27-13-14-29-30(23-27)40-24-39-29/h2-14,23H,15-22,24H2,1H3/b11-7+
InChIKeyNZGSCTUQXQRWEB-YRNVUSSQSA-N
MW541.65 g/mol
LogP3.97
Rot. Bonds10

About N-[2-[4-(1,3-benzodioxole-5-carbonyl)piperazin-1-yl]ethyl]-N-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2-phenylacetamide

N-[2-[4-(1,3-benzodioxole-5-carbonyl)piperazin-1-yl]ethyl]-N-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2-phenylacetamide (PubChem CID 1061272) has the molecular formula C32H35N3O5 and a molecular weight of 541.65 g/mol. Its IUPAC name is N-[2-[4-(1,3-benzodioxole-5-carbonyl)piperazin-1-yl]ethyl]-N-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2-phenylacetamide.

Molecular Properties

Compound NameN-[2-[4-(1,3-benzodioxole-5-carbonyl)piperazin-1-yl]ethyl]-N-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2-phenylacetamide
PubChem CID1061272
Molecular FormulaC32H35N3O5
Molecular Weight541.65 g/mol
Exact Mass541.26
IUPAC NameN-[2-[4-(1,3-benzodioxole-5-carbonyl)piperazin-1-yl]ethyl]-N-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2-phenylacetamide
SMILESCOc1ccccc1/C=C/CN(CCN1CCN(C(=O)c2ccc3c(c2)OCO3)CC1)C(=O)Cc1ccccc1
InChIInChI=1S/C32H35N3O5/c1-38-28-12-6-5-10-26(28)11-7-15-34(31(36)22-25-8-3-2-4-9-25)19-16-33-17-20-35(21-18-33)32(37)27-13-14-29-30(23-27)40-24-39-29/h2-14,23H,15-22,24H2,1H3/b11-7+
InChIKeyNZGSCTUQXQRWEB-YRNVUSSQSA-N
XLogP3.97
TPSA71.55 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds10
Heavy Atoms40
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500541.65
LogP ≤ 53.97
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Analyze N-[2-[4-(1,3-benzodioxole-5-carbonyl)piperazin-1-yl]ethyl]-N-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2-phenylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[2-[4-(1,3-benzodioxole-5-carbonyl)piperazin-1-yl]ethyl]-N-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2-phenylacetamide?
The IUPAC name of N-[2-[4-(1,3-benzodioxole-5-carbonyl)piperazin-1-yl]ethyl]-N-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2-phenylacetamide (CID 1061272) is N-[2-[4-(1,3-benzodioxole-5-carbonyl)piperazin-1-yl]ethyl]-N-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2-phenylacetamide.
What is the SMILES notation for N-[2-[4-(1,3-benzodioxole-5-carbonyl)piperazin-1-yl]ethyl]-N-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2-phenylacetamide?
The canonical SMILES for N-[2-[4-(1,3-benzodioxole-5-carbonyl)piperazin-1-yl]ethyl]-N-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2-phenylacetamide is COc1ccccc1/C=C/CN(CCN1CCN(C(=O)c2ccc3c(c2)OCO3)CC1)C(=O)Cc1ccccc1.
What is the InChIKey of N-[2-[4-(1,3-benzodioxole-5-carbonyl)piperazin-1-yl]ethyl]-N-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2-phenylacetamide?
The InChIKey is NZGSCTUQXQRWEB-YRNVUSSQSA-N. The full InChI is InChI=1S/C32H35N3O5/c1-38-28-12-6-5-10-26(28)11-7-15-34(31(36)22-25-8-3-2-4-9-25)19-16-33-17-20-35(21-18-33)32(37)27-13-14-29-30(23-27)40-24-39-29/h2-14,23H,15-22,24H2,1H3/b11-7+.
What are the key properties of N-[2-[4-(1,3-benzodioxole-5-carbonyl)piperazin-1-yl]ethyl]-N-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2-phenylacetamide?
N-[2-[4-(1,3-benzodioxole-5-carbonyl)piperazin-1-yl]ethyl]-N-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2-phenylacetamide has a molecular weight of 541.65 g/mol, XLogP of 3.97, 10 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[4-(1,3-benzodioxole-5-carbonyl)piperazin-1-yl]ethyl]-N-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-2-phenylacetamide is sourced from PubChem (CID 1061272), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).